Navegar por autor "Gutiérrez, A."

Mostrando ítems 1-7 de 7

Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients

2022- Gutiérrez, A.; Zapater, P.; Ricart, E.; González-Vivó, M.; Gordillo, J.; [et al.]
Management and outcomes of patients with Crohn's disease with first vs multiple surgeries: Results from the PRACTICROHN study

2019- Iborra, M.; Juliá, B.; Arranz, M. D. M.; Barreiro de Acosta, Manuel; Gutiérrez, A.; [et al.]
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry

2022- Zabana, Y.; Marín-Jiménez, I.; Rodríguez-Lago, I.; Vera, I.; Martín-Arranz, M.D.; [et al.]
Perioperative management and early complications after intestinal resection with ileocolonic anastomosis in Crohn's disease: Analysis from the PRACTICROHN study

2019- Gutiérrez, A.; Rivero, M.; Martín-Arranz, M. D.; Garciá Sánchez, V.; Castro, M.; [et al.]
Primary and secondary immunodeficiency diseases in oncohaematology: Warning signs, diagnosis, and management

2019- Sánchez-Ramón, S.; Bermúdez, A.; González-Granado, L.I.; Rodríguez-Gallego, C.; Sastre, A.; [et al.]
Recomendaciones del Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) sobre el tratamiento de pacientes con enfermedad inflamatoria intestinal asociada a espondiloartritis

2020- González-Lama, Y.; Sanz, J.; Bastida, G.; Campos, J.; Ferreiro Iglesias, Rocio; [et al.]
Risk Factors for COVID-19 in Inflammatory Bowel Disease: A National, ENEIDA-Based Case-Control Study (COVID-19-EII)

2022- Zabana, Y.; Marín-Jiménez, I.; Rodríguez-Lago, I.; Vera, I.; Martín-Arranz, M.D.; [et al.]